He Wei-Wu 4
4 · CASI Pharmaceuticals, Inc. · Filed Jun 16, 2021
Insider Transaction Report
Form 4
He Wei-Wu
Director
Transactions
- Award
Stock Options (Right to Buy)
2021-06-15+4,000,000→ 4,000,000 totalExercise: $1.73Exp: 2031-04-27→ Common Stock (4,000,000 underlying)
Footnotes (2)
- [F1]The option grant was approved by the Board of Directors on April 27, 2021, subject to stockholder approval of the option grant. The Company's stockholders approved the option grant on June 15, 2021.
- [F2]The stock options will vest as follows: 25 percent on each of the first, second, third and fourth anniversaries of the date of grant.